Myriad Genetics Expands SRL Partnership in Japan to Support Future Growth
Enhanced partnership expected to strengthen Myriad’s position in its largest international market SALT LAKE CITY, Nov. 17, 2026 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing

Follow